-
Clinical Trials & Development2 days agoGSK’s Hansoh-partnered ADC lays down marker for lung cancer scrap with Merck
GSK’s risvutatug rezetecan has achieved a median overall survival of 18.5 months in a phase 3 trial, painting the antibody-drug conjugate as a threat to Amgen...
-
Clinical Trials & Development3 days agoMRI-Negative Temporal Lobe Epilepsy Reveals Distinct Patient Phenotypes
Italy’s leading epilepsy research centers have joined forces to answer one of neurology’s most stubborn questions: what is actually going on in the brains of patients...
-
Clinical Trials & Development3 days agoWhy Some Treated Sleep Apnea Patients Still Battle Daytime Sleepiness
Excessive daytime sleepiness is one of the most stubborn and disabling symptoms in sleep medicine, and a new exchange in the Journal of Clinical Sleep Medicine...
-
Clinical Trials & Development3 days agoSTAT+: Cancer medicines remain in short supply across the U.S., survey finds
An ongoing shortage of cancer medications continues to force leading cancer centers around the U.S. to seek work-around strategies to treat patients and a majority also...
-
Clinical Trials & Development3 days agoCould UK clinical trial revamp unlock closer ties with Canada?
Two senior figures in Canada's life science sector have said they see scope for greater collaboration with the UK following clinical trial reforms.
-
Clinical Trials & Development3 days ago
AbbVie lines up Qulipta expansion with phase 3 win in untapped menstrual migraine indication
With positive phase 3 results in hand, AbbVie is one step closer to expanding the reach of its key migraine preventative Qulipta, also known as atogepant.
-
Clinical Trials & Development3 days agoSTAT+: Roivant is one of the savviest dealmakers in biotech. It also has a secret weapon
A Roivant lung disease drug has succeeded in a mid-stage study. But the drug’s origins are another fascinating aspect to the story.
Carbon Dots Emerge as a Powerful Weapon Against Superbugs and Biofilms
Your Zip Code May Shape Your Breast Cancer Tumor’s Genetics and Your Survival Odds
Azithromycin Resistance in Gonorrhea Shifts Genetic Ground, Challenging Molecular Surveillance
Scientists turn pig semen extract into eye drops that kill cancer in mice
Novartis to pay $2B upfront to take next-gen PI3Kα inhibitor from Synnovation
